New FDA-approved drug makes severe food allergies less life-threatening
Briefly

This newly approved use for Xolair will provide a treatment option to reduce the risk of harmful allergic reactions among certain patients with IgE-mediated food allergies.
While it will not eliminate food allergies or allow patients to consume food allergens freely, its repeated use will help reduce the health impact if accidental exposure occurs.
Read at Ars Technica
[
]
[
|
]